Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Stryker Corp (NY: SYK )

328.61 +1.98 (+0.60%)
Streaming Delayed Price Updated: 2:41 PM EDT, May 3, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Stryker Corp

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $4,400 Today
Via Benzinga
Stock Market Handles Huge Earnings Week, Fed's Powell, Jobs Report: Weekly Review
The Dow led the major indexes higher. Big techs diverged on results. 
Via Investor's Business Daily
Topics Economy Stocks
Exposures Interest Rates US Equities
Apple Forecasts Weak March-Quarter Sales, Launches Vision Pro
While Apple is forecasting a sales decline in the March quarter, it is upbeat about the rest of the year. Apple stock fell Friday. 
Via Investor's Business Daily
Stryker Stock Sees Relative Strength Rating Jump To 84
The Relative Strength (RS) Rating for Stryker stock jumped into a new percentile Thursday, with a rise from 76 to 84. 
Via Investor's Business Daily
Critical Insights From Stryker Analyst Ratings: What You Need To Know
Via Benzinga
Stryker: Q4 Earnings Insights
Via Benzinga
Earnings Preview For Stryker
Via Benzinga
Biotech And Medtech Portfolio Notes On A Fed Day
The Fed held rates keeping their future options flexible with no expectations for future cuts. The market did not like it and sold off with the Russell 2000 down 2.45% and the NASDAQ down 2.23% 
Via Talk Markets
Topics Economy
Exposures Interest Rates
Why AMD Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Advanced Micro Devices, Inc. (NASDAQ: AMD) shares declined 3.8% to $165.49 following fourth-quarter results. AMD reported fourth-quarter non-GAAP earnings per share of 77 cents per share on... 
Via Benzinga
How Is The Market Feeling About Stryker?
Via Benzinga
Navigating 7 Analyst Ratings For Stryker
Via Benzinga
Here's How Much $100 Invested In Stryker 15 Years Ago Would Be Worth Today
Via Benzinga
STRYKER CORP (NYSE:SYK) Technical Analysis observations.
Technical Insights for STRYKER CORP (NYSE:SYK): Is a Breakout Imminent? 
Via Chartmill
Boeing Posts Upbeat Results, Joins Stryker, Automatic Data Processing And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded mostly lower, with the Nasdaq Composite falling over 200 points on Wednesday. 
Via Benzinga
Topics Stocks
Exposures US Equities
Boston Scientific Surges On Its 'Impressive' First-Quarter Guidance
The company expects sales to grow 7% to 9% organically, above expectations. 
Via Investor's Business Daily
Stryker Expands Prophecy® Surgical Planning System to Include the New Footprint™, Offering Surgeons a Comprehensive View of the Foot and Ankle
From Stryker
Via Business Wire
Stryker, Boston Scientific Score Earnings Beats, Extend Breakouts
Shares of Stryker, Boston Scientific jumped early Wednesday after healthy earnings beats and price target hikes from analysts. 
Via Investor's Business Daily
Topics Earnings
Exposures Financial
4 med tech stocks with improving prognosis for 2024
MedTech stocks have had plenty of reason to rally over the last year but haven't. That is about to change with growth accelerating in 2024 and 2025. 
Via MarketBeat
Exposures COVID-19
Stryker Stock Gains On Q4 Earnings, 2024 Outlook
Stryker Corp (NYSE: SYK) shares are trading higher in Tuesday's after-hours session after the company reported better-than-expected fourth-quarter financial results. 
Via Benzinga
Stryker reports 2023 operating results and 2024 outlook
From Stryker Corporation
Via GlobeNewswire
3 Robotics Stocks to Buy and Hold Forever: January 2024
Wager on these top robotics stocks to buy as the industry kicks in to overdrive offering robust long-term upside. 
Via InvestorPlace
Earnings Scheduled For January 30, 2024
Companies Reporting Before The Bell • CommVault Systems (NASDAQ:CVLT) is estimated to report quarterly earnings at $0.73 per share on revenue of $208.06 million. 
Via Benzinga
Arterial Device-Focused Inari Medical Likely Acquisition Target, Shares Are Attractively Valued: Analyst
Inari Medical with strong position in venous thrombectomy. Buy-rated by Needham with a $72 target. Undervalued shares with an 88% gross margin and anticipated double-digit revenue growth. 
Via Benzinga
New Intermediate Nail and RC Lag Screw Expand Gamma4 Portfolio to Meet the Needs of Surgeons and Their Patients
From Stryker
Via Business Wire
Uber, Abbott Laboratories, Vertex Pharmaceuticals And More On CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Jenny Harrington of Gilman Hill Asset Management named Crown Castle Inc. 
Via Benzinga
First Shoulder Arthroplasty Surgeries Using Stryker’s Blueprint® Mixed Reality Guidance System Completed at Mayo Clinic in Minnesota and at St. Joseph’s Health Care London in Canada
From Stryker
Via Business Wire
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
The 3 Best Robotics Stocks to Buy in January 2024
Get comprehensive insights on market trends and investment opportunities in the robotics sector, staying ahead in this rapidly evolving world. 
Via InvestorPlace
Stryker announces 2023 sales surpassed $20 billion
From Stryker Corporation
Via GlobeNewswire
Stryker to announce financial results for its fourth quarter and full year 2023
From Stryker Corporation
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.